Tag: Quality of Life

BALTIC16: Expert warns of drug resistance in mCRPC patients

Although there are small gains in providing hormone and chemotherapy to metastatic castration-resistant prostate cancer (mCRPC) patient, experts cautioned that the increased use of these new agents may lead to new patterns of resistance. “With increasing use of novel...

EAU15: mCRPC looks at novel research

Much research has been done on new treatment modalities for patients with metastatic castration-resistant prostate cancer (mCRPC) but the cross resistance between these therapies needs to be understood better. Another relative new topic of research is the quality of...